Food use
Food-use source coverage is present in the current record.
The ingredient appears in food-oriented source coverage or allowed-use references, which makes food use easier to support than a context with no domain signal at all.
EPA CPDat observed this chemical in 20925 composition records across product categories including Construction and building materials, Laboratory supplies, Cleaning products and household care.
Concern score
The concern value is driven by the published classifications and regulatory status below — not by a single signal.
Concern score 45/100 (moderate) · high confidence.
Prevalence of ANHYDROUS CITRIC ACID in our catalog (epa_cpdat).
Products
20,925
Brands
6
Typical roles
Context-specific fit derived from published classifications and the current ingredient evidence profile.
Food use
Food-use source coverage is present in the current record.
The ingredient appears in food-oriented source coverage or allowed-use references, which makes food use easier to support than a context with no domain signal at all.
Fragrance avoidance
Not a strong fit for fragrance avoidance because it carries Fragrance.
Primary documents currently linked to this ingredient record.
Structured claim signals pulled from linked ingredient research.
Published jurisdiction-level classifications and regulatory designations for this ingredient.
US
EPA
EPA CPDat observed this chemical in 20925 composition records across product categories including Construction and building materials, Laboratory supplies, Cleaning products and household care. EPA CPDat classifies this chemical for functional uses including Chelating agent, pH regulating agent, Preservative.
The ingredient itself is a fragrance-linked signal, so it is better treated as an avoid case when fragrance exposure is the main concern.
The published evidence profile currently shaping this ingredient record.
US
FDA
Route: BUCCAL; Dosage form: FILM, SOLUBLE; Maximum daily exposure: 2 mg
US
FDA
Route: BUCCAL; Dosage form: TABLET; Maximum daily exposure: 30 mg
US
FDA
Route: INTRACARDIAC; Dosage form: INJECTION; Maximum daily exposure: 25 mg
US
FDA
Route: INTRAMUSCULAR; Dosage form: INJECTION; Maximum daily exposure: 101 mg
US
FDA
Route: INTRAMUSCULAR; Dosage form: INJECTION, SOLUTION; Maximum daily exposure: 25 mg
US
FDA
Route: INTRAVENOUS; Dosage form: CONCENTRATE; Potency: ADJ PH
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION; Maximum daily exposure: 1152 mg
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, FOR SOLUTION; Maximum daily exposure: 35 mg
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Maximum daily exposure: 414 mg
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION, SOLUTION; Maximum daily exposure: 540 mg
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION, SOLUTION, CONCENTRATE; Maximum daily exposure: 81 mg
US
FDA
Route: INTRAVENOUS; Dosage form: LIQUID; Maximum daily exposure: 18 mg
US
FDA
Route: INTRAVENOUS; Dosage form: SOLUTION, CONCENTRATE; Maximum daily exposure: 60 mg
US
FDA
Route: NASAL; Dosage form: SPRAY; Maximum daily exposure: 5 mg
US
FDA
Route: NASAL; Dosage form: SPRAY, METERED; Maximum daily exposure: 1 mg
US
FDA
Route: OPHTHALMIC; Dosage form: SOLUTION; Potency: 0.09 %w/v
US
FDA
Route: OPHTHALMIC; Dosage form: SUSPENSION/ DROPS; Potency: 0.05 %w/v
US
FDA
Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 131 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, LIQUID FILLED; Maximum daily exposure: 360 mg
US
FDA
Route: ORAL; Dosage form: CONCENTRATE; Maximum daily exposure: 84 mg
US
FDA
Route: ORAL; Dosage form: ELIXIR; Maximum daily exposure: 90 mg
US
FDA
Route: ORAL; Dosage form: FILM, SOLUBLE; Maximum daily exposure: 7 mg
US
FDA
Route: ORAL; Dosage form: GRANULE, FOR SUSPENSION; Maximum daily exposure: 30 mg
US
FDA
Route: ORAL; Dosage form: PASTE; Maximum daily exposure: 26 mg
US
FDA
Route: ORAL; Dosage form: POWDER, FOR SOLUTION; Maximum daily exposure: 123 mg
US
FDA
Route: ORAL; Dosage form: POWDER, FOR SUSPENSION; Maximum daily exposure: 570 mg
US
FDA
Route: ORAL; Dosage form: SOLUTION; Maximum daily exposure: 3900 mg
US
FDA
Route: ORAL; Dosage form: SUSPENSION; Maximum daily exposure: 400 mg
US
FDA
Route: ORAL; Dosage form: SUSPENSION, EXTENDED RELEASE; Maximum daily exposure: 62 mg
US
FDA
Route: ORAL; Dosage form: SUSPENSION/ DROPS; Maximum daily exposure: 15 mg
US
FDA
Route: ORAL; Dosage form: SYRUP; Maximum daily exposure: 268 mg
US
FDA
Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 197 mg
US
FDA
Route: ORAL; Dosage form: TABLET, CHEWABLE; Maximum daily exposure: 4 mg
US
FDA
Route: ORAL; Dosage form: TABLET, CHEWABLE, EXTENDED RELEASE; Maximum daily exposure: 12 mg
US
FDA
Route: ORAL; Dosage form: TABLET, EFFERVESCENT; Maximum daily exposure: 840 mg
US
FDA
Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 312 mg
US
FDA
Route: ORAL; Dosage form: TABLET, ORALLY DISINTEGRATING; Maximum daily exposure: 46 mg
US
FDA
Route: ORAL; Dosage form: TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE; Maximum daily exposure: 48 mg
US
FDA
Route: RECTAL; Dosage form: SUSPENSION; Maximum daily exposure: 904 mg
US
FDA
Route: RESPIRATORY (INHALATION); Dosage form: SOLUTION; Maximum daily exposure: 5 mg
US
FDA
Route: RESPIRATORY (INHALATION); Dosage form: SUSPENSION; Maximum daily exposure: 1 mg
US
FDA
Route: SUBCUTANEOUS; Dosage form: INJECTION; Maximum daily exposure: 101 mg
US
FDA
Route: SUBCUTANEOUS; Dosage form: INJECTION, SOLUTION; Maximum daily exposure: 25 mg
US
FDA
Route: SUBLINGUAL; Dosage form: FILM; Maximum daily exposure: 11 mg
US
FDA
Route: SUBLINGUAL; Dosage form: TABLET; Maximum daily exposure: 36 mg
US
FDA
Route: SUBLINGUAL; Dosage form: TABLET, ORALLY DISINTEGRATING; Potency: ADJ PH
US
FDA
Route: TOPICAL; Dosage form: AEROSOL; Potency: 0.08 %w/w
US
FDA
Route: TOPICAL; Dosage form: AEROSOL, FOAM; Maximum daily exposure: 6 mg
US
FDA
Route: TOPICAL; Dosage form: CREAM; Maximum daily exposure: 1 mg
US
FDA
Route: TOPICAL; Dosage form: GEL; Maximum daily exposure: 3 mg
US
FDA
Route: TOPICAL; Dosage form: LOTION; Maximum daily exposure: 211 mg
US
FDA
Route: TOPICAL; Dosage form: OIL; Maximum daily exposure: 2 mg
US
FDA
Route: TOPICAL; Dosage form: SHAMPOO; Potency: 0.07 %w/w
US
FDA
Route: TOPICAL; Dosage form: SPRAY; Potency: 0.01 %w/w
US
FDA
Route: TRANSMUCOSAL; Dosage form: LOZENGE; Maximum daily exposure: 44 mg
US
FDA
FDA NDC lists this ingredient in 75 active drug products and 104 total products.
US
FDA
openFDA substance registry classifies this ingredient as chemical.
US
FDA
Route: TOPICAL; Dosage form: SOLUTION; Potency: 4.35 %w/v
US
FDA
Route: AURICULAR (OTIC); Dosage form: SOLUTION/ DROPS; Maximum daily exposure: 1 mg
US
FDA
Route: BUCCAL; Dosage form: FILM; Maximum daily exposure: 9 mg
US
USDA FoodData Central
Observed in 9 USDA branded foods including 1 LITER BOTTLE BLACKCHERRY, 1 LITER BOTTLE DIET BLACK CHERRY, 1 LITER BOTTLE TOM COLLINS.